Andrew J. Schwab - 03 Aug 2026 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)

Reporting relationship: Director
Issuer ticker: CAMP
Reported as of: 03 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Aug 2026, 17:29:25 UTC
Prior SEC filing: 12 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew J. Schwab

Key filing fact

Andrew J. Schwab filed Form 4 for Camp4 Therapeutics Corp (CAMP) on 05 Aug 2026.

Key facts

This page summarizes Andrew J. Schwab's Form 4 filing for Camp4 Therapeutics Corp (CAMP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Aug 2026, 17:29.

Change

Previous filing in this sequence was filed on 12 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001598549 Primary reporting owner

Schwab Andrew J.

Relationship: Director
Address: C/O 5AM VENTURE MANAGEMENT, LLC, 4 EMBARCADERO CENTER, SUITE 3110, SAN FRANCISCO
Signature: /s/ Andrew J. Schwab
Signature date: 05 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CAMP transaction Derivative

Pre-Funded Warrant (Right to Buy)

Award

Transaction value
Shares: +3,179,558
Change %
Price: $1.53^*
Shares after: 3,179,558
Date: 03 Aug 2026
Ownership: By 5AM Ventures VII, L.P.
Underlying class: Common Stock
Underlying amount: 3,179,558
Exercise price: $0.000100
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Pre-Funded Warrant has no expiration date and is exercisable immediately. Notwithstanding the foregoing, 5AM Ventures VII, L.P. ("Ventures VII") shall not be entitled to exercise the Pre-Funded Warrant to the extent that it would cause the aggregate number of shares of Common Stock beneficially owned by Ventures VII, together with its Attribution Parties (as defined in the Pre-Funded Warrant), to exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise.

Footnote F2

The shares are directly held by Ventures VII. 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. The Reporting Person is a managing member of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.